THE FACT THAT? Kenvue reported sales and profit growth in the first quarter of 2026, supported by improved execution, innovation and margin expansion across its health and beauty portfolio.
THE DETAILS Kenvue reported a 4.5% increase in net sales for the first quarter of 2026, with organic sales increasing 0.7% and diluted earnings per share increasing 47% to $0.25. Adjusted diluted earnings per share increased 33% to $0.32. The company said improvements in gross profits and operating margins were driven by supply chain optimization initiatives, productivity gains and cost reduction programs. Skin Health and Beauty delivered the strongest performance, with net sales up 8.4% and organic sales up 5%, supported by innovations including the expansion of Neutrogena Sun Care in EMEA and the launch of OGX Pro Growth. Essential Health sales increased 4.9%, driven by growth in baby care, oral care and wound care, while personal care sales increased 1.9% despite weaker cold and flu seasons in major markets. Kenvue also confirmed progress on its planned acquisition by Kimberly-Clark, which is expected to close in the second half of 2026 pending regulatory approvals.
THE WHY? The results demonstrate continued resilience in the health, beauty and personal care sector despite macroeconomic uncertainty, while highlighting Kenvue’s focus on operational efficiency, innovation and portfolio strengthening ahead of its merger with Kimberly-Clark.
Fountain: Kenvue
